Clinical Trials

Click here to go to clinicaltrials.gov


View Tips and Talking Points for Supporting a Patient’s Decision
to Enroll in a Clinical Trial Here


Featured Clinical Trials

UF Health Cancer Center

UF Health Cancer Center Clinical Trials

With more than 150 clinical trials open and currently recruiting patients, the UF Health Center has numerous options for patients with refractory malignancies. The February issue of the UF Health Cancer Center Navigator highlights a few of them. For a complete listing of trials available through our system, please click below. View all UF Health...

Gainesville Cancer Center Offers Community Trial Navigation for Local Clinical Research Trials

GAINESVILLE, FL – March 28th, 2018. . . . Florida Cancer Specialists & Research Institute (FCS), is pleased to announce the availability of a local Trial Navigator at Gainesville Cancer Center(GCC), located at 6420 W. Newberry Road, East Wing-Suite 100, Gainesville, FL.  Offering comprehensive care and a wide range of treatments, Gainesville Cancer Center has an established record of broad clinical research...

ENVISION Phase 3 Study

Evaluating the effect of givosiran (ALN-AS1) on the rate of porphyria attacks in patients with Acute Hepatic Porphyrias (AHP). Trial Status: Enrolling Interested in learning more? Please email us at [email protected] For more info: ClinicalTrials.gov – NCT03338816

New Data vs Bicalutamide

Indication XTANDI (enzalutamide) capsules is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). Important Safety Information Contraindications  XTANDI is not indicated for women. XTANDI can cause fetal harm and potential loss of pregnancy. Warnings and Precautions Seizure occurred in 0.5% of patients receiving XTANDI in clinical studies. In placebo-controlled studies, 8 of 1671...

Who’s Online

There are no users currently online